Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

The Next Step in Telehealth Education in a Low-Income Setting: Implementing a Project Echo for Sickle Cell Disease

Samuel Misiani Mbunya, Festus Njuguna, Carole Kilach, Joseph Kipkoech Kirui, Anne Greist, Anthony Betbadal, Seethal A Jacob, Terry Vik, Tyler Severance

Blood (2022) 140 (Supplement 1): 10758–10759.

https://doi.org/10.1182/blood-2022-171020

Published: 2022

Journal Articles

Experience in Surgical Management for Persons with Hemophilia a and with Inhibitors in Western Kenya

Carole Jesang Kilach, Christopher Mwaniki Wanjiku, Joseph Kipkoech Kirui, Racheal Korir, Cyrus Njuguna, Festus Njuguna, Anne Greist

Blood (2021) 138 (Supplement 1): 4948.

https://doi.org/10.1182/blood-2021-148735

Published: 2021

Journal Articles

Sickle Cell Screening in Children in a Resource Constrained Environment: Diagnosis and Follow up

Christopher Mwaniki Wanjiku, Festus Njuguna, Anne Greist, Erick Ayaye, Carole Jesang Kilach, Cyrus Njuguna, Joseph Kirui, John J. Strouse

Blood (2021) 138 (Supplement 1): 4068.

https://doi.org/10.1182/blood-2021-149885

Published: 2021

Journal Articles

Validation and Feasibility of a Point of Care Screening Test for Sickle Cell Disease in a Resource Constrained Setting — a New Frontier

Christopher Mwaniki Wanjiku, MBBS, Festus Njuguna, Fredrick Chite Asirwa, MBBChir, MD MS, Cyrus Njuguna, BSN, Chris Roberson, JD, MPH, Anne Greist, MD

Blood (2018) 132 (Supplement 1): 2229.

https://doi.org/10.1182/blood-2018-99-118876

Published: 2018

Journal Articles

Targeting Transition: a Novel Partnership with Family Medicine to Enhance Quality of Care and Outcomes for Adolescents and Young Adults with Sickle Cell Disease

Emily Riehm Meier, MD MSHS, Amy Dawson, MD, Natalie Duncan, MPH, Dennis O'Brien, MD, Anne Greist, MD

Blood (2017) 130 (Supplement 1): 2077.

https://doi.org/10.1182/blood.V130.Suppl_1.2077.2077

Published: 2017

Journal Articles

Treatment Of Serious Bleeds With a B-Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial

Rebecca Kruse-Jarres, MD, MPH, Jean St. Louis, MD, Anne Greist, MD, Amy D. Shapiro, MD, Hedy Smith, MD PhD, Pratima Chowdary, MBBS, FRCP, FRCPath, Anja B Drebes, MRCP, FRCPath, Edward D. Gomperts, MD, Miranda Chapman, Min Mo, Aaron Novack, PhD, Heinrich D. Farin, MD

Blood (2013) 122 (21): 206.

https://doi.org/10.1182/blood.V122.21.206.206

Published: 2013

Journal Articles

Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results.

Jean St. Louis, MD, Rebecca Kruse-Jarres, MD/MPH, Anne Greist, MD, Amy D. Shapiro, MD, Hedy Smith, MD PhD, Anja B Drebes, MRCP, FRCPath, Jay N. Lozier, MD, PhD, Edward D. Gomperts, MD

Blood (2012) 120 (21): 2224.

https://doi.org/10.1182/blood.V120.21.2224.2224

Published: 2012

Journal Articles

Fondaparinux for the Treatment of Recurrent Venous Thromboembolism During Low Molecular Weight Heparin Therapy: A Retrospective Case Series.

Rashmi Ramasubbaiah, MD, MS, Patrick J Kiel, PharmD, Rakesh Mehta, MD, Anne Greist, MD, Kellie L Jones, PharmD

Blood (2009) 114 (22): 4179.

https://doi.org/10.1182/blood.V114.22.4179.4179

Published: 2009

Journal Articles

Tetrahydrobiopterin (6R-BH4): Novel Therapy for Endothelial Dysfunction in Sickle Cell Disease

Lewis Hsu, MD, PhD, Kenneth I Ataga, M.D., Victor R. Gordeuk, MD, Paul S. Swerdlow, MD, Abdullah Kutlar, MD, Wally Smith, MD, J. Martin Johnston, MD, Ian A Chen, MD, MPH, FACP, Anne Greist, MD, Frances Flug, MD, Susumu Inoue, MD, Olise M. Nwose, MBBS, MRCPath, Saba Sile, MD, Emil Kakkis, MD, PhD

Blood (2008) 112 (11): lba-5.

https://doi.org/10.1182/blood.V112.11.lba-5.lba-5

Published: 2008

Journal Articles

Cardiovascular Disease in Patients with Hemophilia: Single Centre Experience.

Anjali Sharathkumar, MD, Brandy Trawinski, LPN, BLS, J. Michael Soucie, PhD, Anne Greist, MD, Craig Haddix, Amy D. Shapiro, MD

Blood (2008) 112 (11): 2272.

https://doi.org/10.1182/blood.V112.11.2272.2272

Published: 2008

Journal Articles

Bleeding Events and Factor IX Levels in Female Carriers from a Large Kindred of Hemophilia B.

John T. Salter, MD, Brandon Hardesty, MD, Meadow Heiman, Matthew Sulkin, Amy D. Shapiro, MD, Anne Greist, MD

Blood (2007) 110 (11): 1150.

https://doi.org/10.1182/blood.V110.11.1150.1150

Published: 2007

Journal Articles

A Tiered Management Program To Conserve Replacement Therapy Resources for a Rural Population of Women with Type 2M von Willebrand Disease during Labor and Delivery.

John T. Salter, MD, Amy D. Shapiro, MD, Matt Sulkin, Meadow Heiman, Anne Greist, MD, Patsy Yoder, Jennifer Maahs

Blood (2007) 110 (11): 3961.

https://doi.org/10.1182/blood.V110.11.3961.3961

Published: 2007

Journal Articles

A Prospective Comparision of Intranasal (I.N.) and Subcutaneous (S.C.) Desmopressin (DDAVP) Therapy in Type 2M Von Willebrand Disease (VWD).

Scott Herbert, MD, Rekha Parameswaran, MD, Amy D. Shapiro, MD, Jorge Di Paola, MD, Jon Winay, Chris Roberson, Anne Greist, MD

Blood (2006) 108 (11): 1035.

https://doi.org/10.1182/blood.V108.11.1035.1035

Published: 2006

Journal Articles

Framingham Score in Congenital Hemophilia Patients (HP) with Cardiovascular Disease (CVD).

Rekha Parameswaran, MD, Anne Greist, MD, Lorrie Miller-Rice, MD, Chris Roberson, Renee Murry, Matthew Sulkin, Henry Lynn, Amy Shapiro, MD

Blood (2005) 106 (11): 320.

https://doi.org/10.1182/blood.V106.11.320.320

Published: 2005

Journal Articles

High Dose Intranasal Desmopressin (DDAVP) Therapy in Type 2M Von Willebrand Disease (VWD): A Prospective Open Label Trial.

Rekha Parameswaran, MD, Jorge Di Paola, MD, Lorrie Miller-Rice, MD, Anne Greist, MD, Amy D. Shapiro, MD

Blood (2005) 106 (11): 1783.

https://doi.org/10.1182/blood.V106.11.1783.1783

Published: 2005

NARROW

The Next Step in Telehealth Education in a Low-Income Setting: Implementing a Project Echo for Sickle Cell Disease

Experience in Surgical Management for Persons with Hemophilia a and with Inhibitors in Western Kenya

Sickle Cell Screening in Children in a Resource Constrained Environment: Diagnosis and Follow up

Validation and Feasibility of a Point of Care Screening Test for Sickle Cell Disease in a Resource Constrained Setting — a New Frontier

Targeting Transition: a Novel Partnership with Family Medicine to Enhance Quality of Care and Outcomes for Adolescents and Young Adults with Sickle Cell Disease

Treatment Of Serious Bleeds With a B-Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial

Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results.

Fondaparinux for the Treatment of Recurrent Venous Thromboembolism During Low Molecular Weight Heparin Therapy: A Retrospective Case Series.

Tetrahydrobiopterin (6R-BH4): Novel Therapy for Endothelial Dysfunction in Sickle Cell Disease

Cardiovascular Disease in Patients with Hemophilia: Single Centre Experience.

Bleeding Events and Factor IX Levels in Female Carriers from a Large Kindred of Hemophilia B.

A Tiered Management Program To Conserve Replacement Therapy Resources for a Rural Population of Women with Type 2M von Willebrand Disease during Labor and Delivery.

A Prospective Comparision of Intranasal (I.N.) and Subcutaneous (S.C.) Desmopressin (DDAVP) Therapy in Type 2M Von Willebrand Disease (VWD).

Framingham Score in Congenital Hemophilia Patients (HP) with Cardiovascular Disease (CVD).

High Dose Intranasal Desmopressin (DDAVP) Therapy in Type 2M Von Willebrand Disease (VWD): A Prospective Open Label Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only